Login with your work email address to view charts. No credit card required.
| Art Unit: | 1658 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1650 — Enzymology, Microbiology, and Fermentation, Small Peptides and Bioacting Plant, Microbial and Animal Extracts |
| Classes: |
514 — Drug, bio-affecting and body treating compositions 530 — Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof 424 — Drug, bio-affecting and body treating compositions 435 — Chemistry: molecular biology and microbiology 606 — Surgery 506 — Combinatorial chemistry technology: method, library, apparatus 800 — Multicellular living organisms and unmodified parts thereof and related processes |
| Phone: | (571) 272-5538 |
| Email: | amber.steele@uspto.gov |
| Location: | VA 22314 |
| Title: | Pat Examnr Computer Science |
| Service: | 21 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 60% over 369 cases |
|---|---|
| Difficulty: | Harder |
| Difficulty Percentile: | 72nd
|
With Examiner Steele, you have a 60% chance of getting an issued patent by 3 years after the first office action. Examiner Steele is a harder examiner and in the 72nd percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Steele, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Steele's grant rate is higher than that of Art Unit 1658 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Steele | 1.3 |
| Art Unit 1658 | 1.7 |
Examiner Steele has granted 193 of 324 cases without any applicant-requested interviews for a grant rate of 60%.
Examiner Steele has granted 28 of 45 cases with at least one applicant-requested interview for a grant rate of 62%.
With Examiner Steele, conducting an interview increases your chance of getting a patent granted by 3%.
| Number | Title | OA Rejections | Status | IFW |
|---|---|---|---|---|
| 18590842 | Modifications Of Peptide Compositions To Increase Stability And Delivery Efficiency | Rejection information available with a Premium Stats subscription. See our pricing. | Abandoned | View |
| 17636735 | Use Of Inhibitors Of Yap And Sox2 For The Treatment Of Cancer | Abandoned | View | |
| 18033452 | Muscular Function Improving Agent For Skeletal Muscle Of Which Function Is Degraded Due To Aging | Abandoned | View | |
| 18446172 | Peptides And Methods For The Treatment Of Diabetes | Patented | View | |
| 17280605 | Immunity-Inducing Agent Comprising Antigen Peptide-Adjuvant Nucleotide Conjugate And Pharmaceutical Composition Comprising Same | Patented | View | |
| 18834531 | Recombinant Humanized Collagen Type Iii Alpha-1, And Expression Vector And Use Thereof | Patented | View | |
| 18578613 | Self-Assembling Peptide Amphiphiles Displaying A Transforming Growth Factor Beta 1 (Tgf-SS1) Mimetic Epitope | Patented | View | |
| 18031762 | Antimicrobial Compositions And Methods Of Use | Patented | View | |
| 17774873 | Tumor-Specific Polypeptide Sequence And Use Thereof | Patented | View | |
| 17800818 | Molecules Targeting Ras Protein | Abandoned | View | |
| 17602733 | Compositions And Methods To Manufacture Tumor Suppressor Fusions | Abandoned | View | |
| 17612979 | Compositions And Methods For The Treatment And Prevention Of Hypoglycemic Complications | Abandoned | View | |
| 19192339 | Antimicrobial Peptide And Application Thereof | Abandoned | View | |
| 18031978 | Glp-1/gip Dual Agonist, Long-Acting Conjugate Thereof, And Pharmaceutical Composition Comprising Same | Patented | View | |
| 17641539 | Application Of Non-Igf1r-Binding Substance In Prevention And/or Treatment Of Inflammatory Diseases | Abandoned | View | |
| 18697004 | Tricyclic Polypeptide Conjugated Drug And Use Thereof | Patented | View | |
| 17844647 | Methods Of Treating Neurological Diseases | Abandoned | View | |
| 17635561 | Metal-Binding Peptide, And Use Thereof | Abandoned | View | |
| 17423244 | Methods And Compositions For Modulating Immune Dysregulation | Abandoned | View | |
| 19172886 | Pam3csk4 Injection For The Prevention And Management Of Masld | Patented | View | |
| 17355587 | Compositions And Methods Comprising Histidyl-Trna Synthetase Splice Variants Having Non-Canonical Biological Activities | Patented | View | |
| 18829844 | Peptide Compositions Capable Of Binding Lanthionine Synthetase C-Like Protein (Lancl) And Uses Thereof | Patented | View | |
| 18058134 | Peptide Compositions And Methods For Inhibiting Nicotinic Acetylcholine Receptor Activity | Abandoned | View | |
| 17632463 | Melanocyte-Regulating Peptides | Patented | View | |
| 16611063 | Norrin Induced Expression Of Genes And Use Thereof To Treat Disease | Patented | View | |
| 18584321 | Peptide Used For Immunotherapeutics | Patented | View | |
| 18118587 | Autologous And Allogenic Hiv-1 Proteins For The Treatment Of Latent Hiv-1 Infection | Patented | View | |
| 18008034 | Pharmaceutical Composition For Enhancing Radiotherapy Comprising Fusion Protein Containing Il-2 Protein And Cd80 Protein | Patented | View | |
| 17260824 | Compositions And Methods For Identification Assessment, Prevention, And Treatment Of Ewing Sarcoma Using Tp53 Dependency Biomarkers And Modulators | Patented | View | |
| 18011155 | Inhalation Formulations Of Antimicrobial Compounds | Patented | View | |
| 17639547 | A Peptide Used For Immunotherapeutics | Abandoned | View | |
| 19207094 | Leptin Compositions And Methods Of Making And Using The Same To Support Weight Loss And/or Maintenance | Patented | View | |
| 17995992 | Prevention And Treatment Of Organ Injuries | Patented | View | |
| 17281884 | Compositions And Methods For The Treatment Of Pathogenic Infections In Plants | Abandoned | View | |
| 17556572 | Platforms, Compositions, And Methods For Therapeutic Delivery | Abandoned | View | |
| 19024178 | Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production | Abandoned | View | |
| 17385862 | Scalable Three-Dimensional Elastic Construct Manufacturing | Abandoned | View | |
| 18853789 | Treatment For Ocular Fibrosis | Patented | View | |
| 18524461 | Compositions And Methods For Treating Endometriosis | Patented | View | |
| 18390354 | Molecular Guide System Peptides And Uses Thereof | Patented | View | |
| 16972241 | Proteins And Their Use For Nucleotide Binding | Patented | View | |
| 18424386 | Heterotandem Bicyclic Peptide Complex | Patented | View | |
| 18081964 | Hydrogel For Cell-Laden Bioprinting, Bioink, And Preparation Method And Application Thereof | Patented | View | |
| 17439166 | Mutant Vsv Ectodomain Polypeptide And Uses Thereof | Patented | View | |
| 17440901 | Gpcr Combination Therapies | Abandoned | View | |
| 18612627 | Human Collagen 17-Type Polypeptide, Production Method Therefor And Use Thereof | Patented | View | |
| 18612612 | Human Collagen 17-Type Polypeptide, Production Method Therefor And Use Thereof | Patented | View | |
| 18304159 | Gelatin Particles, Method For Producing Gelatin Particles, Gelatin Particle-Containing Cell, And Method For Producing Gelatin Particle-Containing Cell | Patented | View | |
| 18306911 | Recombinant Cdhr3 Protein Fragments Inhibit Rhinovirus C Binding And Replication | Patented | View | |
| 17604328 | Peptide-Based Non-Proteinaceous Cargo Delivery | Patented | View |
Subscribe to Premium Examiner Statistics for unlimited access for your law firm.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.